KGW Interview with Brian Druker and Rob Shick on the Topic of Gleevec
Over 15 years ago, our teammate Rob Shick was diagnosed with Chronic Myeloid Leukemia. He has a heartening story of his and his families’ journey through this experience. At the center Rob’s recovery is the development of a medication called Gleevec developed at the OHSU Knight Cancer Institute by a world-renowned researcher named Dr. Brian Druker.
